Interobserver variation in assessment of gastric premalignant lesions: Higher agreement for intestinal metaplasia than for atrophy

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 6, 2013, Pages 694-699

  Leja, Marcis ^a,b   Funka, Konrads ^a   Janciauskas, Dainius ^a,c   Putnins, Viesturs ^d   Ruskule, Agnese ^a,b   Kikuste, Ilze ^c   Kojalo, Una ^c   Tolmanis, Ivars ^a   Misins, Janis ^c   Purmalis, Karlis ^e   Pimanov, Sergey ^c   Makarenko, Jelena ^c   Kupcinskas, Limas ^c   Vikmanis, Uldis ^c  

^a UNIVERSITY OF LATVIA   (Latvia)

^b RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^c LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^d Digestive Diseases Centre GASTRO   (Latvia)

^e VITEBSK STATE MEDICAL UNIVERSITY   (Belarus)

Author keywords

atrophic gastritis; histopathology; interobserver variations; intestinal metaplasia; OLGA; OLGIM

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH ANTRUM; STOMACH ATROPHY; STOMACH BIOPSY; STOMACH MUCOSA;

AGED; ATROPHY; BIOPSY; CLINICAL COMPETENCE; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; METAPLASIA; MIDDLE AGED; OBSERVER VARIATION; PRECANCEROUS CONDITIONS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 84877073487     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835e3397     Document Type: Article

References (39)

1. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report. Gut 2012; 61:646-664.
2. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94.
3. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-1181.
4. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-1259.
5. Antonioli DA. Gastric carcinoma and its precursors in Gastrointestinal Pathology. Baltimore: Williams & Wilkins1990; p. 144.
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
7. El-Zimaity H. Gastritis and gastric atrophy. Curr Opin Gastroenterol 2008; 24:682-686.
8. Imagawa S, Yoshihara M, Ito M, Yoshida S, Wada Y, Tatsugami M, et al. Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study. Dig Dis Sci 2008; 53:1818-1823.
9. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35:173-177.
10. De Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter 2007; 12 (Suppl 2):22-31.
11. Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002; 16:1209-1216.
12. Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001; 15:983-998.
13. de Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007; 56: 1665-1670.
14. Ruiz B, Garay J, Correa P, Fontham ET, Bravo JC, Bravo LE, et al. Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001; 96: 3281-3287.
15. Staibano S, Rocco A, Mezza E, De Rosa G, Budillon G, Nardone G. Diagnosis of chronic atrophic gastritis by morphometric image analysis. A new method to overcome the confounding effect of the inflammatory infiltrate. J Pathol 2002; 198:47-54.
16. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Moreira-Dias L. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2007; 22: 1594-1604.
17. Uedo N, Ishihara R, Iishi H, Yamamoto S, Yamamoto S, Yamada T, et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006; 38: 819-824.
18. Pimentel-Nunes P, Dinis-Ribeiro M, Soares JB, Marcos-Pinto R, Santos C, Rolanda C, et al. A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions. Endoscopy 2012; 44:236-246.
19. Alaboudy AA, Elbahrawy A, Matsumoto S, Yoshizawa A. Conventional narrow-band imaging has good correlation with histopathological severity of Helicobacter pylori gastritis. Dig Dis Sci 2011; 56:1127-1130.
20. Jung SW, Lim KS, Lim JU, Jeon JW, Shin HP, Kim SH, et al. Flexible spectral imaging color enhancement (FICE) is useful to discriminate among non-neoplastic lesion, adenoma, and cancer of stomach. Dig Dis Sci 2011; 56:2879-2886.
21. Zhang JN, Li YQ, Zhao YA, Yu T, Zhang JP, Guo YT, et al. Classification of gastric pit patterns by confocal endomicroscopy. Gastrointest Endosc 2008; 67:843-853.
22. Matalka II, Al-Omari FA, Al-Jarrah MA, Obeidat FN, Kanaan FM. Image-based discriminating morphological features for gastric atrophy assessment: a step to go further. Pathol Res Pract 2008; 204:235-240.
23. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012; 460:19-46.
24. Price AB, Misiewicz JJ. Sydney classification for gastritis. Lancet 1991; 337:174.
25. Sipponen P, Kekki M, Siurala M. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6: 244-251.
26. Plummer M, Buiatti E, Lopez G, Peraza S, Vivas J, Oliver W, et al. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol 1997; 26:716-720.
27. Chen XY, van der Hulst RW, Bruno MJ, van der Ende A, Xiao SD, Tytgat GN, et al. Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol 1999; 52:612-615.
28. Guarner J, Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, et al. Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol 1999; 30:1431-1434.
29. Rugge M, Genta RM. Staging gastritis: an international proposal. Gastroenterology 2005; 129:1807-1808.
30. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010; 31: 1104-1111.
31. Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71:1150-1158.
32. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci 2009; 54: 2377-2384.
33. Aydin O, Egilmez R, Karabacak T, Kanik A. Interobserver variation in histopathological assessment of Helicobacter pylori gastritis. World J Gastroenterol 2003; 9:2232-2235.
34. El-Zimaity HM, Graham DY, al-Assi MT, Malaty H, Karttunen TJ, Graham DP, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996; 27: 35-41.
35. Offerhaus GJ, Price AB, Haot J, ten Kate FJ, Sipponen P, Fiocca R, et al. Observer agreement on the grading of gastric atrophy. Histopathology 1999; 34:320-325.
36. Rugge M, Kim JG, Mahachai V, Miehlke S, Pennelli G, Russo VM, et al. OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol 2008; 16:150-154.
37. Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, et al. Operative link for gastritis assessment vs. operative link on intestinal metaplasia assessment. World J Gastroenterol 2011; 17:4596-4601.
38. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48:3554-3560.
39. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15:885-891.